COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,157 Articles (22,703 medRxiv, 8,454 bioRxiv)

Most recent first Previous |  Page 1185: Articles 11841-11850  | Next

Inhibition of SARS-CoV-2 spike protein palmitoylation reduces virus infectivity
Ramadan, A. A., Mayilsamy, K., McGill, A. R., Ghosh, A., Giulianotti, M. A., Donow, H. M., Mohapatra, S. S., Mohapatra, S., Chandran, B., Deschenes, R. J., Roy, A.
10.1101/2021.10.07.463402 — Posted: 2021-10-08
A bacteria-based assay to study SARS-CoV-2 protein-protein interactions
Hochschild, A., Springstein, B. L., Deighan, P., Grabe, G.
10.1101/2021.10.07.463611 — Posted: 2021-10-08
Non-invasive Imaging of Sense of Smell by Tracking the Voltage-Gated Sodium Channel NaV1.7
Adilbay, D., Gonzales, J., Demetrio de Souza Franca, P., Roberts, S., Patel, S., Viray, T., Chow, C. Y., King, G. F., Jain, S. K., Ordonez, A. A., Caroll, L. S., Pillarsetty, N., Reiner, T.
10.1101/2021.10.07.463532 — Posted: 2021-10-08
Compositional analysis of Sindbis virus ribonucleoproteins reveals an extensive co-opting of key nuclear RNA-binding proteins
Kamel, W., Ruscica, V., Garcia-Moreno, M., Palmalux, N., Iselin, L., Hannan, M., Järvelin, A., Noerenberg, M., Moore, S., Merits, A., Davis, I., Martinez, J., Mohammed, S., Castello, A.
10.1101/2021.10.06.463336 — Posted: 2021-10-08
High-throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain
Dasovich, M. A., Zhou, J., Thomas, A. G., Goodman, J. A., McPherson, R. L., Jayabalan, A. K., Busa, V. F., Cheng, S.-J., Murphy, B., Redinger, K. R., Tsukamoto, T., Slusher, B. S., Bosch, J., Wei, J., Leung, A.
10.1101/2021.10.07.463234 — Posted: 2021-10-07
Monitoring sociodemographic inequality in COVID-19 vaccination coverage in England: a national linked data study
Dolby, T., Finning, K., Baker, A., Dowd, L., Khunti, K., Razieh, C., Yates, T., Nafilyan, V.
10.1101/2021.10.07.21264681 — Posted: 2021-10-07
Protection Across Age Groups of BNT162b2 Vaccine Booster against Covid-19
Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., Ash, N., Huppert, A., Milo, R.
10.1101/2021.10.07.21264626 — Posted: 2021-10-07 Discussion: Offsite
TITLE: Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
Quinn, T. M., Gaughan, E. E., Bruce, A., Antonelli, J., O'Connor, R., Li, F., McNamara, S., Koch, O., MacIntosh, C., Dockrell, D., Walsh, T., Blyth, K., Church, C., Schwarze, J., Boz, C., Valanciute, A., Burgess, M., Emanuel, P., Mills, B., Rinaldi, G., Hardisty, G., Mills, R., Findlay, E., Jabbal, S., Duncan, A., Plant, S., Marshall, A. D. L., Young, I., Russell, K., Scholefield, E., Nimmo, A. F., Nazarov, I. B., Churchill, G. C., McCullagh, J. S. O., Ebrahimi, K., Ferrett, C., Templeton, K., Rannard, S., Owen, A., Moore, A., Finlayson, K., Shankar-Hari, M., Norrie, J., Parker, R. A., Akram, A. R., Anthony, D. C., Dear, J. W., Hirani, N., Dhaliwal, K.
10.1101/2021.10.06.21264648 — Posted: 2021-10-07
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination
Garrett, M. E., Galloway, J. G., Wolf, C., Logue, J. K., Franko, N., Chu, H. Y., Matsen, F., Overbaugh, J. M.
10.1101/2021.10.05.463210 — Posted: 2021-10-07
Defective neutralizing antibody response to SARS-CoV-2 in vaccinated dialysis patients
Bassi, J., Giannini, O., Silacci-Fregni, C., Pertusini, L., Hitz, P., Terrot, T., Franzosi, Y., Muoio, F., Saliba, C., Meury, M., Dellota, E., Dillen, J., Hernandez, P., Czudnochowski, N., Cameroni, E., Beria, N., Ventresca, M., Badellino, A., Lavorato-Hadjeres, S., Lecchi, E., Bonora, T., Mattiolo, M., Trinci, G., Garzoni, D., Bonforte, G., Forni-Ogna, V., Giunzioni, D., Berwert, L., Gupta, R. K., Ferrari, P., Ceschi, A., Cippa', P., Corti, D., Lanzavecchia, A., Piccoli, L.
10.1101/2021.10.05.21264054 — Posted: 2021-10-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).